Understand hemoglobinopathies in newborns
Learn the basics of sickle cell disease and thalassemias and their impact on newborn health.
Importance of Hemoglobinopathy screening in newborns
Hemoglobinopathies, including sickle cell disease and thalassemias, are among the most common inherited blood disorders worldwide. Early detection through newborn screening is critical for initiating timely interventions that can significantly improve health outcomes and reduce morbidity and mortality. This webinar will explore the clinical significance of hemoglobinopathy screening in newborns, review current screening methodologies, and discuss global strategies for implementing effective screening programs. Attendees will gain valuable insights into the benefits of early diagnosis and the role of public health initiatives in managing these conditions from infancy.
What will you learn?
Recognize the importance of newborn screening
Understand how early detection improves outcomes through timely diagnosis and intervention.
Discover current screening methodologies
Explore the main methods used to screen newborns for hemoglobinopathies.
Explore global implementation strategies
Learn about successful approaches to developing and expanding newborn screening programs worldwide.
Appreciate the impact of early diagnosis
Discover how early diagnosis and public health initiatives improve lifelong disease management.
“Newborn screening enables early diagnosis before symptom onset, dramatically reducing childhood morbidity and mortality”
About Raquel Yahyaoui
Raquel Yahyaoui is a Clinical Biochemist at Málaga Regional University Hospital and has served as Coordinator of the Newborn Screening Center of Eastern Andalusia since 2009.
She has extensive expertise in newborn screening, particularly in the early detection of congenital disorders using tandem mass spectrometry and advanced post-analytical tools.
Her work focuses on expanding and improving newborn screening programs, including hemoglobinopathy screening, and she actively contributes to the development of international laboratory standards through her collaboration with the Clinical and Laboratory Standards Institute (CLSI).
Deepen your expertise with additional webinars
Educational Webinar with Dr.Matthew C. Wagner
Educational Webinar with David G. Grenache, PhD, D(ABCC) Chief Scientific Officer, TriCore Reference Laboratories
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.